Anticoagulants, Antiplatelets, and Thrombolytics.pdf

B IOLOGY TM

M ETHODS IN M OLECULAR

Series Editor

John M. Walker

School of Life Sciences

University of Hertfordshire

Hatﬁeld, Hertfordshire, AL10 9AB, UK

For other titles published in this series, go to

www.springer.com/series/7651

Anticoagulants, Antiplatelets,

and Thrombolytics

Second Edition

Edited by

Shaker A. Mousa

Pharmaceutical Research Institute, Albany College of Pharmacy

and Health Sciences, Rensselaer, NY, USA

Editor

Shaker A. Mousa

Albany College of Pharmacy

and Health Sciences

Pharmaceutical Research Institute

One Discovery Drive

Rensselaer, NY 12144

USA

shaker.mousa@acphs.edu

ISSN 1064-3745

e-ISSN 1940-6029

ISBN 978-1-60761-802-7

e-ISBN 978-1-60761-803-4

DOI 10.1007/978-1-60761-803-4

Springer New York Dordrecht Heidelberg London

Library of Congress Control Number: 2010929846

the publisher (Humana Press, c/o Springer Science+Business Media, LLC, 233 Spring Street, New York, NY 10013,

USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of

information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology

now known or hereafter developed is forbidden.

The use in this publication of trade names, trademarks, service marks, and similar terms, even if they are not identiﬁed

as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights.

While the advice and information in this book are believed to be true and accurate at the date of going to press, neither

the authors nor the editors nor the publisher can accept any legal responsibility for any errors or omissions that may

be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

Printed on acid-free paper

Humana Press is part of Springer Science+Business Media (www.springer.com)